Medline Inc. Class A Common Stock Defensive Interval Ratio
Medline Inc. Class A Common Stock defensive interval ratio. Medline Inc. Class A Common Stock (MDLN) has a Defensive Interval Ratio of 540 days as of June 2026. Defensive assets of $4.01 Billion (cash $-, short-term investments $350.00 Million, receivables $3.66 Billion) cover 540 days of daily cash needs of $7.42 Million/day. See Medline Inc. Class A Common Stock short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of Medline Inc. Class A Common Stock (2023–2025)
Defensive interval ratio of Medline Inc. Class A Common Stock from 2023 to 2025. This chart shows how Medline Inc. Class A Common Stock's Defensive Interval Ratio has evolved across 3 annual periods from 2023 to 2025. As of June 2026, the ratio stands at 540 days, meaning defensive assets of $4.01 Billion can fund 540 days of operations without new revenue. Check Medline Inc. Class A Common Stock (MDLN) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Medline Inc. Class A Common Stock Defensive Interval Ratio by Year (2023–2025)
Medline Inc. Class A Common Stock defensive interval ratio by year from 2023 to 2025. The table below presents the year-by-year Defensive Interval Ratio for Medline Inc. Class A Common Stock from 2023 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see Medline Inc. Class A Common Stock total assets.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 518 days | $3.53 Billion | $6.82 Million/day | $- | $- | ▲ +36 days |
| 2024 | 482 days | $3.22 Billion | $6.68 Million/day | $- | $- | ▼ -25 days |
| 2023 | 507 days | $2.96 Billion | $5.84 Million/day | $- | $- | — |